|
Title
|
|
|
|
Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Purpose TSPO PET imaging may hold promise as a single-step diagnostic work-up for clinical immunopsychiatry. This review paper on the clinical applicability of TSPO PET for primary psychiatric disorders discusses if and why TSPO PET imaging might become the first clinical immunopsychiatry biomarker and the investment prerequisites and scientific advancements needed to accommodate this transition from bench to bedside. Methods We conducted a systematic search of the literature to identify clinical studies of TSPO PET imaging in patients with primary psychiatric disorders. We included both original case-control studies as well as longitudinal cohort studies of patients with a primary psychiatric diagnosis. Results Thirty-one original studies met our inclusion criteria. In the field of immunopsychiatry, TSPO PET has until now mostly been studied in schizophrenia and related psychotic disorders, and to a lesser extent in mood disorders and neurodevelopmental disorders. Quantitative TSPO PET appears most promising as a predictive biomarker for the transdiagnostic identification of subgroups or disease stages that could benefit from immunological treatments, or as a prognostic biomarker forecasting patients' illness course. Current scanning protocols are still too unreliable, impractical and invasive for clinical use in symptomatic psychiatric patients. Conclusion TSPO PET imaging in its present form does not yet offer a sufficiently attractive cost-benefit ratio to become a clinical immunopsychiatry biomarker. Its translation to psychiatric clinical practice will depend on the prioritising of longitudinal research and the establishment of a uniform protocol rendering clinically meaningful TSPO uptake quantification at the shortest possible scan duration without arterial cannulation. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
European journal of nuclear medicine and molecular imaging. - Heidelberg, 2002, currens
|
|
|
Publication
|
|
|
|
New york
:
Springer
,
2021
|
|
|
ISSN
|
|
|
|
1619-7070
[print]
1619-7089
[online]
|
|
|
DOI
|
|
|
|
10.1007/S00259-021-05308-0
|
|
|
Volume/pages
|
|
|
|
49
:1
(2021)
, p. 164-173
|
|
|
ISI
|
|
|
|
000630277500002
|
|
|
Pubmed ID
|
|
|
|
33735406
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|